Two Sigma Advisers LP Has $3.62 Million Stock Holdings in Chimera Investment Co. (NYSE:CIM)

Two Sigma Advisers LP lifted its stake in shares of Chimera Investment Co. (NYSE:CIM - Free Report) by 32.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 258,828 shares of the real estate investment trust's stock after purchasing an additional 62,700 shares during the quarter. Two Sigma Advisers LP owned about 0.32% of Chimera Investment worth $3,624,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in CIM. Barclays PLC increased its position in Chimera Investment by 301.6% in the 3rd quarter. Barclays PLC now owns 183,295 shares of the real estate investment trust's stock valued at $2,901,000 after acquiring an additional 137,655 shares during the period. SG Americas Securities LLC increased its position in Chimera Investment by 39.2% in the 4th quarter. SG Americas Securities LLC now owns 21,138 shares of the real estate investment trust's stock valued at $296,000 after acquiring an additional 5,951 shares during the period. Manning & Napier Advisors LLC increased its position in Chimera Investment by 66.7% in the 4th quarter. Manning & Napier Advisors LLC now owns 100,000 shares of the real estate investment trust's stock valued at $1,400,000 after acquiring an additional 40,000 shares during the period. Empowered Funds LLC acquired a new stake in Chimera Investment in the 4th quarter valued at approximately $264,000. Finally, BostonPremier Wealth LLC acquired a new stake in Chimera Investment in the 4th quarter valued at approximately $204,000. 48.44% of the stock is currently owned by institutional investors and hedge funds.

Chimera Investment Stock Down 1.3%

NYSE:CIM traded down $0.17 during trading hours on Friday, reaching $13.18. The company's stock had a trading volume of 553,138 shares, compared to its average volume of 593,127. The company has a market cap of $1.07 billion, a price-to-earnings ratio of 12.20 and a beta of 1.76. Chimera Investment Co. has a one year low of $9.85 and a one year high of $16.89. The business's 50-day moving average is $12.32 and its 200-day moving average is $13.62. The company has a debt-to-equity ratio of 2.82, a current ratio of 0.06 and a quick ratio of 3.03.

Chimera Investment (NYSE:CIM - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The real estate investment trust reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.38 by $0.03. Chimera Investment had a net margin of 20.28% and a return on equity of 7.00%. The firm had revenue of $69.22 million during the quarter, compared to analysts' expectations of $72.07 million. Equities research analysts predict that Chimera Investment Co. will post 1.57 EPS for the current year.

Chimera Investment Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st were issued a dividend of $0.37 per share. This represents a $1.48 dividend on an annualized basis and a yield of 11.23%. The ex-dividend date was Monday, March 31st. Chimera Investment's dividend payout ratio (DPR) is 98.67%.

Insider Activity at Chimera Investment

In related news, Director Gerard Creagh bought 12,500 shares of Chimera Investment stock in a transaction that occurred on Tuesday, March 11th. The stock was acquired at an average price of $13.31 per share, for a total transaction of $166,375.00. Following the completion of the purchase, the director now owns 138,127 shares in the company, valued at approximately $1,838,470.37. This represents a 9.95% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.91% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

CIM has been the topic of several research analyst reports. UBS Group upgraded Chimera Investment from a "neutral" rating to a "buy" rating and lifted their price target for the company from $11.50 to $15.00 in a research report on Wednesday, May 14th. Royal Bank of Canada upgraded shares of Chimera Investment to a "moderate buy" rating in a report on Friday, March 14th. Finally, Wall Street Zen upgraded Chimera Investment from a "hold" rating to a "buy" rating in a report on Thursday, May 15th. Two research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $15.50.

Chimera Investment Profile

Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities.